# Story Consistency Audit

Stage 6 Readiness Check

## Purpose

This audit checks whether the current company strategy documents tell one consistent startup story.

It does not rewrite existing documents.
It does not modify product code.
It does not change UI.
It does not add features.

It only identifies inconsistencies and recommends exact future edits.

## Source Documents Reviewed

- `company/CODEX_OPERATING_SYSTEM.md`
- `company/01_PRODUCT_IDENTITY.md`
- `company/02_COMPETITIVE_WEDGE.md`
- `company/03_CATEGORY_DESIGN.md`
- `company/04A_BUSINESS_MODEL_AND_PMF.md`
- `company/04B_PRODUCT_BLUEPRINT.md`
- `company/04C_REVENUE_JOURNEY_BLUEPRINT.md`
- `company/05_EVIDENCE_PLAN.md`
- `README.md`

Requested but missing:

- `company/MASTER_REVIEW.md`

Available Stage 5A source used instead:

- root-level `MASTER_REVIEW.md`

## Executive Summary

The company is close to telling one coherent story, but it is not fully aligned yet.

The strongest unified story is:

> Review-to-Revenue AI helps founder-led Franchise / Business Consulting operators turn messy customer conversations into revenue actions, starting with a free diagnostic and paid Revenue Action Report before any larger SaaS build.

The main strategic loop is consistent across most documents:

```text
Customer Voice
-> Revenue Signal
-> Revenue Action
-> Outcome Data
-> Better Recommendations
```

The biggest issue is that early documents still speak like a broad product/category strategy, while later documents correctly shift toward evidence-first validation.

The largest contradiction:

> `01_PRODUCT_IDENTITY.md` says the first ICP is Clinics / med spas, while later documents say the first beachhead is Franchise / Business Consulting.

The second largest contradiction:

> Several documents recommend moving to a Master PRD next, while `MASTER_REVIEW.md` and `05_EVIDENCE_PLAN.md` say the current decision is No-Go on product build and Go only on evidence validation.

Consistency score:

> 74 / 100

Why not higher:

- First customer is inconsistent.
- Category language shifts between AI Revenue Intelligence Platform, Revenue Action Platform, and Revenue Intelligence Layer.
- First offer language shifts between free Revenue Action Report, free Revenue Leak Diagnostic, and free diagnostic report.
- Stage sequencing conflicts: some docs say Master PRD next; later docs say evidence first.
- `company/MASTER_REVIEW.md` is referenced but missing.

Why not lower:

- Core pain is consistent.
- Competitive wedge is consistent.
- Non-goals are consistent.
- Revenue journey is broadly consistent.
- Evidence gaps are now clearly defined in Stage 5A and 5B.

## Consistency Table

| Question | Consistent? | Conflicting Documents | Best Final Answer | Fix Needed |
| --- | --- | --- | --- | --- |
| 1. Who is the first customer? | No | `01_PRODUCT_IDENTITY.md` chooses Clinics / med spas; `02_COMPETITIVE_WEDGE.md`, `04A_BUSINESS_MODEL_AND_PMF.md`, `04B_PRODUCT_BLUEPRINT.md`, `05_EVIDENCE_PLAN.md`, and `MASTER_REVIEW.md` choose Franchise / Business Consulting. | First customer is a founder-led Franchise / Business Consulting operator with recurring inbound leads, messy lead notes, repeated objections, and high-value consultations. Clinics / med spas become second expansion candidate. | Update `01_PRODUCT_IDENTITY.md` first. Then check README/demo copy for vertical priority. |
| 2. What is their core pain? | Mostly yes | Minor wording variation across all docs. | Leads go cold because follow-up is generic, repeated objections are not turned into content/scripts, and no one tracks what happened after action. | Standardize the core pain sentence across product, business, and journey docs. |
| 3. What category are we creating? | Mostly yes | `01_PRODUCT_IDENTITY.md` says AI Revenue Intelligence Platform for Customer Voice; `03_CATEGORY_DESIGN.md` recommends Revenue Action Platform for customers and Revenue Intelligence Layer for Customer Voice for investors. | Customer-facing category: Revenue Action Platform for Customer Voice. Investor-facing phrase: Revenue Intelligence Layer for Customer Voice. Product name: Review-to-Revenue AI. | Update `01_PRODUCT_IDENTITY.md` category wording to match `03_CATEGORY_DESIGN.md`. |
| 4. Why are existing tools not enough? | Yes | No major conflict. | Review tools summarize and reply; CRMs store records; reputation tools manage public trust; CX tools report trends; AI sales tools assist execution. None owns the loop from customer voice to revenue action to outcome learning for small high-consideration operators. | Minor copy standardization only. |
| 5. Why not just ChatGPT? | Mostly yes | Earlier docs mention generic AI risk but do not define a hard proof test; `05_EVIDENCE_PLAN.md` defines the clearest ChatGPT comparison experiment. | ChatGPT can draft text, but the product must prove superior diagnosis, evidence, prioritization, vertical judgment, execution, outcome loop, and paid packaging. | Add the `05_EVIDENCE_PLAN.md` ChatGPT test into Product Identity / Competitive Wedge later. |
| 6. What is the first offer? | Partly | `04A_BUSINESS_MODEL_AND_PMF.md` says Free Revenue Leak Diagnostic; `04C_REVENUE_JOURNEY_BLUEPRINT.md` often says Free Revenue Action Report; `05_EVIDENCE_PLAN.md` uses "Send 10-20 notes. Get 3 revenue leaks and 3 follow-up actions." | First offer: Free Revenue Leak Diagnostic from 10-20 anonymized customer conversations. Paid first offer: Revenue Action Report at KRW 390,000 / $299 test price. | Rename free offer consistently. Avoid calling the free offer a full Revenue Action Report. |
| 7. What is the revenue journey? | Mostly yes | `04C_REVENUE_JOURNEY_BLUEPRINT.md` gives full journey; `MASTER_REVIEW.md` and `05_EVIDENCE_PLAN.md` warn not to assume later SaaS stages before evidence. | Founder-led outreach -> free Revenue Leak Diagnostic -> review call -> paid Revenue Action Report -> action execution -> outcome follow-up -> setup or monthly refresh only if evidence supports it. | Reframe journey as validation sequence, not guaranteed SaaS funnel. |
| 8. What evidence is still missing? | Yes after Stage 5B | Earlier docs imply evidence needs; `MASTER_REVIEW.md` and `05_EVIDENCE_PLAN.md` make them explicit. | Missing evidence: data sharing, paid demand, action execution, outcome reporting, weekly return behavior, ChatGPT superiority, and first-market pull. | Add short evidence gate references to earlier docs after validation. |
| 9. What should we NOT build yet? | Yes | No major conflict. | Do not build auth, payments, Supabase, OpenAI API, CRM sync, scraping, auto messaging, enterprise admin, complex analytics, mobile app, or new product features before validation. | Keep consistent. Add "do not build more product until evidence passes" to older docs. |
| 10. What is the current Go / No-Go decision? | No | `03_CATEGORY_DESIGN.md`, `04A_BUSINESS_MODEL_AND_PMF.md`, and `04C_REVENUE_JOURNEY_BLUEPRINT.md` recommend Master PRD next; `MASTER_REVIEW.md` and `05_EVIDENCE_PLAN.md` say No-Go on product build and Go on evidence sprint only. | Product build: No-Go. Evidence sprint: Go. Stage 6 Master PRD only if evidence thresholds pass. | Update all "Master PRD next" statements to "Master PRD only after Stage 5B evidence passes." |

## Major Inconsistencies

### 1. First Customer Conflict

`01_PRODUCT_IDENTITY.md` names Clinics / med spas as the primary ICP and Wedding vendors as secondary.

Later documents shift the first beachhead to Franchise / Business Consulting because:

- founder-market fit is strongest,
- the founder understands the workflow,
- objections are known,
- customer language is accessible,
- manual validation can start faster,
- paid report delivery is more plausible without integrations.

This is the biggest story problem because every later decision depends on the first customer.

Final recommendation:

> Make Franchise / Business Consulting the first customer everywhere. Keep Clinics / med spas as the second expansion candidate.

### 2. Stage Sequence Conflict

Several documents say the next step should be Master PRD.

But Stage 5A and Stage 5B changed the decision:

- Product build: No-Go.
- Evidence sprint: Go.
- Master PRD: conditional.

This is not a small wording issue. It changes company behavior.

Final recommendation:

> Replace all "Master PRD next" language with "Evidence Plan first; Master PRD only if evidence thresholds pass."

### 3. First Offer Naming Conflict

The free offer is currently called:

- Free diagnostic report.
- Free Revenue Leak Diagnostic.
- Free Revenue Action Report.
- Free Revenue Action Report from 10-20 reviews or sales notes.

This creates confusion between the free teaser and the paid artifact.

Final recommendation:

- Free offer: **Free Revenue Leak Diagnostic**
- Paid offer: **Revenue Action Report**
- Setup offer: **Revenue Action System Setup**
- Later recurring offer: **Monthly Action Refresh** before calling it SaaS

### 4. Category Language Drift

Current category labels:

- AI Revenue Intelligence Platform for Customer Voice.
- Revenue Action Platform.
- Revenue Action Platform for Customer Voice.
- Revenue Intelligence Layer for Customer Voice.
- Customer Voice Revenue Intelligence.

These can coexist only if hierarchy is explicit.

Final recommendation:

```text
Product name:
Review-to-Revenue AI

Customer-facing category:
Revenue Action Platform for Customer Voice

Investor-facing phrase:
Revenue Intelligence Layer for Customer Voice

Do not use as primary customer copy yet:
AI Revenue Intelligence Platform
RevenueOS
```

### 5. SaaS Assumption Drift

Some documents describe the full SaaS journey as if it will happen.

Stage 5A and 5B correctly challenge this. The company has not proven:

- customers return weekly,
- customers record outcomes,
- customers want a subscription,
- reports convert to setup,
- setup converts to recurring usage.

Final recommendation:

> Treat SaaS as a hypothesis, not the next build target.

## Minor Inconsistencies

### 1. "Customer Voice" vs "Customer Conversations"

Documents use both terms.

Best use:

- Use "customer conversations" in first-touch customer copy.
- Use "customer voice" in category and strategic docs.

Reason:

- "Customer conversations" is more concrete for small operators.
- "Customer voice" is broader and useful for category language.

### 2. "Revenue at Risk" vs "Recovered Revenue"

The README and product blueprint include `Revenue at Risk`, while later reviews warn that revenue estimates may feel fake.

Best use:

- Say "estimated conversation value" during validation.
- Avoid hard revenue claims until outcomes exist.

### 3. Demo Vertical Priority

The app currently has hotel, wedding, and clinic demos. Later docs say Korean Franchise Consulting should be first validation mode.

Best use:

- Keep existing demos as synthetic examples.
- Add or prioritize Korean Franchise Consulting as the primary sales demo later.
- Do not remove existing demos during this audit.

### 4. "Report Is Not Product" vs Report-Led GTM

Documents say reports are not the product, but the business model starts with reports.

This is not fatal if framed correctly:

- Report is not the long-term product.
- Report is the first paid validation package.

### 5. 14-Day Plan vs 90-Day Plan

`04A_BUSINESS_MODEL_AND_PMF.md` defines a 14-day validation plan.
`05_EVIDENCE_PLAN.md` defines a 90-day roadmap.

Best use:

- 14-day plan becomes Phase 1.
- 90-day plan becomes full validation sprint.

## Final Recommended Unified Story

Review-to-Revenue AI is a Revenue Action Platform for Customer Voice.

It starts with founder-led Franchise / Business Consulting operators who have high-value leads, recurring inbound inquiries, messy sales notes, and repeated objections around investment, payback period, risk, brand comparison, location, operator workload, and family approval.

Their core pain is not that they lack another dashboard. Their pain is that customer conversations already reveal why leads go cold, but those signals do not become specific follow-up messages, content topics, script improvements, or tracked outcomes.

Existing tools are incomplete:

- Review tools tell them what customers said.
- CRMs store who is in the pipeline.
- Reputation tools manage public trust.
- CX tools report trends.
- AI writing tools draft generic copy.

Review-to-Revenue AI should prove a narrower promise first:

> Send 10-20 anonymized customer conversations. Get a Free Revenue Leak Diagnostic showing the top leaks and next actions.

The first paid offer is:

> Revenue Action Report at KRW 390,000 / $299.

The product should not be built further until evidence shows that customers:

- share usable customer voice data,
- value the diagnostic,
- pay for the report,
- execute recommended actions,
- report outcomes,
- and ask for setup or recurring refresh.

Current Go / No-Go:

- Product build: **No-Go**
- Evidence sprint: **Go**
- Master PRD: **Conditional after evidence**

## Documents That Need Updating

### Highest Priority

1. `company/01_PRODUCT_IDENTITY.md`
2. `company/03_CATEGORY_DESIGN.md`
3. `company/04A_BUSINESS_MODEL_AND_PMF.md`
4. `company/04C_REVENUE_JOURNEY_BLUEPRINT.md`

### Medium Priority

5. `company/04B_PRODUCT_BLUEPRINT.md`
6. `README.md`
7. `company/02_COMPETITIVE_WEDGE.md`

### Structural Fix

8. Move or copy root `MASTER_REVIEW.md` into `company/MASTER_REVIEW.md`, or update future references to the root path.

## Exact Edits Recommended

Do not apply these edits yet. These are recommendations only.

### `company/01_PRODUCT_IDENTITY.md`

Replace:

> Primary ICP: Clinics / med spas

With:

> Primary ICP: Franchise / Business Consulting

Replace:

> Secondary ICP: Wedding vendors

With:

> Secondary ICP: Clinics / med spas

Add a note:

> Clinics / med spas remain commercially attractive, but Franchise / Business Consulting is the first validation market because founder-market fit and customer language access are strongest.

Replace:

> AI Revenue Intelligence Platform for Customer Voice

With:

> Revenue Action Platform for Customer Voice

Add:

> Investor-facing category phrase: Revenue Intelligence Layer for Customer Voice.

### `company/03_CATEGORY_DESIGN.md`

Replace the Stage 5 recommendation:

> Master PRD for the Revenue Action Platform MVP.

With:

> Evidence Plan and Kill Criteria first. Master PRD only after evidence thresholds pass.

Add:

> Current product build decision: No-Go until Stage 5B evidence validates data sharing, paid demand, action execution, and outcome reporting.

### `company/04A_BUSINESS_MODEL_AND_PMF.md`

Keep the 14-day plan, but relabel it:

> Phase 1 of the 90-day validation sprint.

Add:

> The 14-day plan is not enough to justify product build. It only validates whether deeper 90-day evidence collection is worth continuing.

### `company/04B_PRODUCT_BLUEPRINT.md`

Add before MVP Product Definition:

> This blueprint is conditional. Do not implement more surfaces until Stage 5B evidence passes.

Add under Demo Modes:

> Korean Franchise Consulting Demo should become the primary validation demo. Existing hotel, wedding, and clinic demos remain synthetic supporting examples.

### `company/04C_REVENUE_JOURNEY_BLUEPRINT.md`

Replace:

> Get a free Revenue Action Report from 10-20 reviews or sales notes.

With:

> Get a Free Revenue Leak Diagnostic from 10-20 anonymized customer conversations.

Replace:

> Free Revenue Action Report

With:

> Free Revenue Leak Diagnostic

Where the free offer is described.

Add:

> Monthly SaaS is not the assumed next step. It is only valid if customers execute actions, report outcomes, and request recurring refresh.

### `company/02_COMPETITIVE_WEDGE.md`

Add a ChatGPT-specific section:

> Why not just ChatGPT?

Include:

- generic prompts can draft text,
- Review-to-Revenue must prove better diagnosis, evidence, prioritization, vertical judgment, execution, and outcome learning,
- Stage 5B side-by-side ChatGPT comparison is required.

### `README.md`

Add a validation status note:

> Current company decision: product build is paused. The project is in evidence validation mode before Master PRD.

Update demo section later to prioritize Franchise / Business Consulting once the demo exists.

### File Location Fix

Either:

1. Move root `MASTER_REVIEW.md` to `company/MASTER_REVIEW.md`, or
2. Update future prompts/docs to reference root `MASTER_REVIEW.md`.

Best recommendation:

> Move Stage 5A review into `company/MASTER_REVIEW.md` later so all company strategy docs live under `company/`.

## Go / No-Go Alignment

### Current Decision

Product build:

> No-Go

Evidence sprint:

> Go

Master PRD:

> Conditional

### Why

The company has a coherent wedge but lacks proof.

Evidence still missing:

- Customers will share data.
- Customers will pay.
- Customers will execute actions.
- Customers will report outcomes.
- Customers will return weekly.
- Customers will prefer this over ChatGPT.

The company should not move to product implementation until Stage 5B thresholds are met.

## Final Answer

Are we telling one coherent startup story?

> Not yet, but we are close.

The core story is coherent:

> Customer conversations contain revenue signals. Review-to-Revenue AI turns them into revenue actions and learns from outcomes.

But the startup story is not fully coherent because:

- the first customer changed from Clinics / med spas to Franchise / Business Consulting,
- the first offer is named inconsistently,
- category language is layered but not always explained,
- older docs still imply Master PRD should come next,
- later docs say evidence must come first,
- and the Stage 5A review file is not in the requested `company/` path.

Final recommendation:

> Align the documents around Franchise / Business Consulting, Free Revenue Leak Diagnostic, Paid Revenue Action Report, Revenue Action Platform for Customer Voice, and No-Go on product build until evidence thresholds pass.
